Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Washington, District of Columbia
- Most recent report
- 10-Q, filed Aug 14, 2026
- Incorporated
- Delaware
- Filings on record
- 216 filings
- On EDGAR
- CIK 1946563
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company Emerging growth company
Financials 8 of 13
News 8 of 44
Prospectuses and Registrations 8 of 26
- S-3 Shelf registration statement Aug 14, 2026
- 424B5 Prospectus supplement for an offering Mar 13, 2026
- 424B5 Prospectus supplement for an offering Mar 11, 2026
- 424B5 Prospectus supplement for an offering Mar 2, 2026
- 424B5 Prospectus supplement for an offering Sep 5, 2025
- 424B4 Final prospectus for an offering Jul 16, 2025
- S-1 Registration statement for an offering Jul 7, 2025
- S-1/A Registration statement for an offering, amended Mar 27, 2025
Proxies 8 of 9
- DEF 14A Proxy statement for a shareholder vote Jul 2, 2026
- PRE 14A Preliminary proxy statement Jun 8, 2026
- DEFR14A Sep 2, 2025
- DEF 14A Proxy statement for a shareholder vote Aug 27, 2025
- PRE 14A Preliminary proxy statement Aug 15, 2025
- DEF 14A Proxy statement for a shareholder vote Oct 15, 2024
- PRE 14A Preliminary proxy statement Oct 2, 2024
- DEF 14A Proxy statement for a shareholder vote May 30, 2024
Ownership 8 of 61
- SCHEDULE 13G Large holder reported a passive stake Aug 5, 2026
- 3 Insider reported their initial holding Jul 29, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 29, 2026
- 4 Insider reported a trade Jun 15, 2026
- 3 Insider reported their initial holding May 19, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 15, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 15, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 13, 2026
Other 8 of 63
- DEL AM Aug 17, 2026
- EFFECT Notice that a registration became effective Jul 15, 2025
- CORRESP Reply to SEC staff Jul 10, 2025
- CORRESP Reply to SEC staff Jul 10, 2025
- UPLOAD Comment letter from SEC staff Jun 13, 2025
- DRS Draft registration statement, submitted confidentially Jun 6, 2025
- EFFECT Notice that a registration became effective Apr 2, 2025
- CORRESP Reply to SEC staff Mar 31, 2025
Everything here comes from 60 Degrees Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.